Gainers
- IMAC Hldgs BACK stock increased by 84.5% to $1.53 during Tuesday's pre-market session. The market value of their outstanding shares is at $3.1 million.
- Hepion Pharmaceuticals HEPA shares increased by 30.3% to $0.21. The company's market cap stands at $1.4 million.
- Ocean Biomedical OCEA stock rose 21.57% to $0.42. The company's market cap stands at $14.5 million.
- OneMedNet ONMD shares increased by 13.2% to $1.2. The market value of their outstanding shares is at $33.5 million.
- Qualigen Therapeutics QLGN stock rose 13.08% to $4.49. The market value of their outstanding shares is at $3.3 million.
- BioVie BIVI shares rose 11.23% to $1.98. The company's market cap stands at $35.1 million.
Losers
- Sharps Technology STSS shares decreased by 58.2% to $0.61 during Tuesday's pre-market session. The market value of their outstanding shares is at $1.2 million.
- Gelteq GELS stock decreased by 17.72% to $2.23. The market value of their outstanding shares is at $21.0 million.
- Klotho Neurosciences KLTO shares decreased by 16.09% to $0.36. The company's market cap stands at $8.3 million.
- AirSculpt Technologies AIRS stock fell 15.79% to $4.0. The market value of their outstanding shares is at $231.5 million.
- Onconetix ONCO stock decreased by 15.36% to $0.54. The company's market cap stands at $4.5 million.
- Cyclacel Pharmaceuticals CYCC stock declined by 13.16% to $0.33. The market value of their outstanding shares is at $3.7 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
BACKIMAC Holdings Inc
$0.82002.89%
BIVIBioVie Inc
$1.761.67%
CYCCCyclacel Pharmaceuticals Inc
$0.36783.26%
GELSGelteq Ltd
$2.75-%
HEPAHepion Pharmaceuticals Inc
$0.19027.46%
KLTOKlotho Neurosciences Inc
$0.42502.41%
OCEAOcean Biomedical Inc
$0.25133.37%
ONCOOnconetix Inc
$0.5800-4.93%
ONMDOneMedNet Corp
$1.061.91%
QLGNQualigen Therapeutics Inc
$3.463.59%
STSSSharps Technology Inc
$0.3721-1.61%
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in